Preoperative Sonography of Malignant Ovarian Neoplasms

Obstetrical & Gynecological Survey ◽

10.1097/00006254-198202000-00022 ◽

1982 ◽

Vol 37 (2) ◽

pp. 116-117

Author(s):

C. KENNETH REQUARD ◽

FRED A. METTLER ◽

JEFFERY D. WICKS

Keyword(s):

Ovarian Neoplasms ◽

Preoperative Sonography

Download Full-text

Preoperative sonography of malignant ovarian neoplasms

American Journal of Roentgenology ◽

10.2214/ajr.137.1.79 ◽

1981 ◽

Vol 137 (1) ◽

pp. 79-82 ◽

Author(s):

CK Requard ◽

FA Mettler ◽

JD Wicks

Keyword(s):

Ovarian Neoplasms ◽

Preoperative Sonography

Download Full-text

The pathological assessment of ovarian neoplasms. IV: The sex cord-stromal tumours

Pathology ◽

10.3109/00313028109081664 ◽

1981 ◽

Vol 13 (2) ◽

pp. 235-255 ◽

Author(s):

David C. Gee ◽

P. Russell

Keyword(s):

Ovarian Neoplasms ◽

Pathological Assessment

Download Full-text

Human medicines European public assessment report (EPAR): Mvasi, bevacizumab, Carcinoma, Renal Cell,Peritoneal Neoplasms,Ovarian Neoplasms,Breast Neoplasms,Carcinoma, Non-Small-Cell Lung,Fallopian Tube Neoplasms, Date of authorisation: 14/01/2018, Revision: 3, Status: Authorised

Case Medical Research ◽

10.31525/cmr-4e9a82 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Ovarian Neoplasms ◽

Small Cell Lung ◽

Assessment Report ◽

Peritoneal Neoplasms ◽

European Public ◽

European Public Assessment Report ◽

Fallopian Tube Neoplasms ◽

Carcinoma Renal Cell

Download Full-text

Human medicines European public assessment report (EPAR): Yondelis, trabectedin, Ovarian Neoplasms,Sarcoma, Date of authorisation: 17/09/2007, Revision: 24, Status: Authorised

Case Medical Research ◽

10.31525/cmr-2935cd6 ◽

2020 ◽

Author(s):

Keyword(s):

Ovarian Neoplasms ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Doxolipad, doxorubicin, Breast Neoplasms,Ovarian Neoplasms, Date of refusal: 08/08/2019, Status: Refused

Case Medical Research ◽

10.31525/cmr-1b3641e ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Ovarian Neoplasms ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Lynparza, olaparib, Ovarian Neoplasms, Date of authorisation: 16/12/2014, Revision: 7, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1378e0a ◽

2019 ◽

Author(s):

Keyword(s):

Ovarian Neoplasms ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Mvasi, bevacizumab, Carcinoma, Renal Cell,Peritoneal Neoplasms,Ovarian Neoplasms,Breast Neoplasms,Carcinoma, Non-Small-Cell Lung,Fallopian Tube Neoplasms, Date of authorisation: 14/01/2018, Revision: 4, Status: Authorised

Case Medical Research ◽

10.31525/cmr-58719b ◽

2019 ◽

Author(s):

Keyword(s):

Breast Neoplasms ◽

Ovarian Neoplasms ◽

Small Cell Lung ◽

Assessment Report ◽

Peritoneal Neoplasms ◽

European Public ◽

European Public Assessment Report ◽

Fallopian Tube Neoplasms ◽

Carcinoma Renal Cell

Download Full-text

Human medicines European public assessment report (EPAR): Zejula, niraparib, Fallopian Tube Neoplasms,Peritoneal Neoplasms,Ovarian Neoplasms, Date of authorisation: 16/11/2017, Revision: 4, Status: Authorised

Case Medical Research ◽

10.31525/cmr-837c9b ◽

2019 ◽

Author(s):

Keyword(s):

Fallopian Tube ◽

Ovarian Neoplasms ◽

Assessment Report ◽

Peritoneal Neoplasms ◽

European Public ◽

European Public Assessment Report ◽

Fallopian Tube Neoplasms

Download Full-text

Comparative Evaluation of Intraoperative Cytology and Histopathology in Ovarian Neoplasms

International Journal of Pharmaceutical Research ◽

10.31838/ijpr/2020.sp2.330 ◽

2020 ◽

Vol 12 (sp2) ◽

Keyword(s):

Comparative Evaluation ◽

Ovarian Neoplasms ◽

Intraoperative Cytology

Download Full-text

Faculty Opinions recommendation of Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717976556.793472766 ◽

2013 ◽

Author(s):

David Kushner ◽

Ryan Spencer

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

International Collaboration ◽

Ovarian Neoplasms ◽

Randomised Trial ◽

Advanced Ovarian Cancer ◽

Life Outcomes ◽

Standard Chemotherapy ◽

Download Full-text